万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温
- 保质期:
三年
- 英文名:
pTet-On-Advanced
- 库存:
60
- 供应商:
信裕生物
- 规格:
5ug质粒
基本信息
| 质粒类型: | 四环素调控系统 |
|---|---|
| 启动子: | CMV |
| 克隆方法: | 多克隆位点,限制性内切酶 |
| 载体大小: | 7139 bp (查看载体序列) |
| 载体抗性: | Ampicillin (氨苄青霉素) |
| 筛选标记: | Neomycin(新霉素) |
订购信息
| 产品编号 | 产品名称 | 规格 | 价格 |
|---|---|---|---|
| XY1603 | pTet-On-Advanced | 5ug质粒 |
¥1000.00 |
质粒图谱
载体描述
pTet-On-Advanced expresses an improved version of the reverse Tet (tetracycline)-controlled transactivator protein (rtTA), called rtTA-Advanced (1–4). It is more sensitive to doxycycline (Dox) and yields lower background expression than the original rtTA used in the Tet-On® System (2). The rtTA-Advanced protein is a fusion of amino acids 1–207 of a mutant Tet repressor (TetR) and 39 amino acids containing three minimal "F"-type transcriptional activation domains from the VP16 protein of herpes simplex virus. It is fully synthetic, lacks cryptic splice sites, and is codon-optimized for stable expression in mammalian cells.
载体应用
The pTet-On-Advanced Vector is used to develop stable Tet-On Advanced cell lines, which are hosts for a Dox-induced gene expression system. Once a vector containing a gene of interest under control of a Tet-responsive element (e.g., TRE-Tight or TRE2) is transfected into a Tet-On Advanced cell line, rtTA-Advanced binds to the TRE, and activates transcription of the gene of interest in the presence of Dox in a highly dose-dependent manner. Additional information on TRE-containing vectors and protocols describing the construction of Tet-On Advanced cell lines can be found in the Tet-On Advanced Inducible Gene Expression System User Manual (PT3898-1).
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验。该系统发挥作用的机制如图所示。 Tet―on和Tet―off系统的作用机制采用该系统进行条件性基因敲除时,要将受特异性启动子调控的tTA的表达载体转入小鼠体内,同时还要将受Ptet 启动子调控的Cre重组酶的表达载体也转入小鼠体内。这样一个转基因小鼠与loxP的转基因小鼠进行交配,产生的子代小鼠中会在特定组织和器官中表达tTA,tTA再与Ptet 结合后激活下游的Cre重组酶的表达,实现特定基因在特定组织器官中的敲除。如果在子代小鼠出生时就给予四环素,并且一直维持下去,特定基因的敲除
Adv Funct Mater:开发原位活化 NK 细胞纳米载体,增强实体瘤免疫治疗
近日,由中国科学院深圳先进技术研究院研究员蔡林涛领衔的纳米医学研究小组,在基于生物正交糖代谢及纳米技术的 NK 细胞工程改造方面取得新突破,相关论文《基于生物正交靶向的活细胞纳米载体原位活化 NK 细胞增强实体瘤免疫治疗的研究》(In Situ Activated NK Cell as Bio-Orthogonal Targeted Live-Cell Nanocarrier Augmented Solid Tumor Immunotherapy)在线发表在《先进功能材料》上(Advanced
在目的基因起始密码子ATG前加上这一个序列 pVL1393, 昆虫表达载体 pIEX/Bac-1 昆虫表达载体 pTET on pTeT off pTER-tight pBAD HisA amp pBAD myc HisA amp pACYC184 amp pBluescript II SK (+) amp pIRESneo3 pPICZ α B pVL1393, pIEX/Bac-1 pcmv-myc P2
技术资料暂无技术资料 索取技术资料




